Latest Flibanserin Stories
SADDLE BROOK, N.J., Jan. 6, 2011 /PRNewswire/ -- The FDA's nod to a new testosterone gel for men will expand the options they have to address the problems of sexual dysfunction. "So where does this leave women?" asks Rachel Braun Scherl, president of Semprae Laboratories, Inc.
â€œPink Viagra,â€ an experimental pill claiming to boost a womanâ€™s sex drive, has been scrapped by German maker Boehringer Ingelheim after failing to convince US regulators that the pill actually worked.
Drug companies have not only sponsored the science of a new condition known as female sexual dysfunction, they have helped to construct it, in order to build global markets for new drugs, reveals an article in this week's BMJ.
On Friday, a US panel of experts debated to approve the first pill that helps boost a woman's sex drive, as its German manufacturer pressed for the drug to reach the lucrative market.
RIDGEFIELD, Conn., June 18 /PRNewswire/ -- The Reproductive Health Drugs Advisory Committee met today to discuss the new drug application (NDA) for flibanserin 100 mg as a treatment for Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women.
The drug industryâ€™s latest attempt to find a female equivalent to Viagra fell short in two separate studies, according to federal regulators on Wednesday.
Data from pivotal Phase III clinical trials demonstrate that a higher proportion of pre-menopausal women with Hypoactive Sexual Desire Disorder (HSDD) receiving flibanserin 100mg reported both an improvement in their condition and a meaningful benefit from their treatment, compared to placebo.
- An armed gangster.